Polaris® Glycerol-free Reverse Transcriptase Y 2 kU/µL, IVD, is a validated Class A IVD reagent, intended for professional use in the real-time PCR detection of RNA virus. This enzyme is uniquely formulated to be compatible with lyophilization, facilitating its inclusion in diagnostic kits that require freeze-drying for enhanced stability and ease of transport. Developed for high-speed, thermostability, and resistance to RT-qPCR inhibitors, Polaris® Glycerol-free Reverse Transcriptase Y 1 kU/µL, IVD, enables the generation of full-length cDNA fragments in minimized reaction times, as brief as one minute. Its enhanced thermostability permits successful transcription at temperatures up to 70 °C. Patent pending submitted by NZYtech.
Details
Polaris® Glycerol-free Reverse Transcriptase Y 2 kU/µL, IVD, designed for in vitro diagnostic (IVD) applications, represents a significant advancement in the field of molecular diagnostics, addressing the urgent need for rapid and reliable testing in global health contexts. Along with Polaris® Glycerol-free HS TaqY Polymerase 28 U/µL, IVD, and Polaris® Glycerol-free RNase Inhibitor Y 160 U/µL, IVD, this enzyme is part of a second generation of molecular diagnostic enzymes tailored for RT-qPCR clinical applications. Provided in a high-concentration, glycerol-free formulation, it is especially suited for lyophilization, benefiting clinical settings where shipping and storage conditions can impact diagnostic test viability and where maintaining a cold chain may pose challenges.
Developed for high-speed, thermostability, and resistance to RT-qPCR inhibitors, Polaris® Glycerol-free Reverse Transcriptase Y 2 kU/µL,